Literature DB >> 28472352

Association Between Serum Lipoprotein(a) and Diabetic Retinopathy in Han Chinese Patients With Type 2 Diabetes.

Wen-Jun Tu1,2, Huan Liu3, Qiang Liu1, Jian-Lei Cao4, Min Guo3.   

Abstract

Context: Contrasting observations have been made on the relationship between lipoprotein(a) [Lp(a)] concentration and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D). Objective: To measure serum Lp(a) concentrations in patients with T2D to investigate whether Lp(a) affects risk for DR. Design and Patients: Serum Lp(a) was determined in 377 Han Chinese patients with T2D. Demographic and clinical information, including presence of DR and vision-threatening DR (VTDR), were collected on admission. The relationship between serum Lp(a) and DR or VTDR was evaluated using univariate and multivariate regression analyses.
Results: Patients with DR or VTDR had significantly higher serum Lp(a) concentrations on admission (P < 0.001). The distribution across Lp(a) quartiles ranged from 11.7% (DR) and 4.3% (VTDR) in the first quartile to 47.9% (DR) and 19.1% (VTDR) in the fourth quartile (P for trend < 0.001). Multivariate logistic regression analysis adjusted for common DR and VTDR risk factors showed that the third and fourth Lp(a) quartiles were significantly associated with DR and VTDR compared with the first Lp(a) quartile (P < 0.001). The patient group with highest concentrations of both Lp(a) (fourth quartile) and hemoglobin A1c (≥7%) had an odds ratio for DR of 5.15 [95% confidence interval (CI), 2.78 to 9.55; P < 0.001] and for VTDR of 5.32 (95% CI, 2.92 to 10.15; P < 0.001) compared with patients with lower concentrations of both factors. Conclusions: Lp(a) concentration was independently associated with DR in patients with T2D. More frequent retinal examinations should be recommended for patients with T2D and high Lp(a) concentrations.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28472352     DOI: 10.1210/jc.2016-4015

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.

Authors:  Haoliang Wang; Jun Zhao; Yongkun Gui; Haiqing Yan; Zhixin Yan; Ping Zhang; Li Liu; Li Chang; Jianlong Zhang
Journal:  Neurotox Res       Date:  2017-12-20       Impact factor: 3.911

2.  Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes.

Authors:  Jia-Ying Li; Xian-Xian Chen; Xiao-Hua Lu; Chuang-Biao Zhang; Qi-Ping Shi; Lie Feng
Journal:  Biosci Rep       Date:  2018-09-12       Impact factor: 3.840

3.  Serum lipoprotein (a) associates with a higher risk of reduced renal function: a prospective investigation.

Authors:  Liping Xuan; Tiange Wang; Huajie Dai; Bin Wang; Jiali Xiang; Shuangyuan Wang; Hong Lin; Mian Li; Zhiyun Zhao; Jieli Lu; Yuhong Chen; Yu Xu; Weiqing Wang; Min Xu; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2020-07-23       Impact factor: 5.922

4.  Correlation between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Diabetic Macular Edema.

Authors:  Eleni Dimitriou; Theodoros N Sergentanis; Vaia Lambadiari; George Theodossiadis; Panagiotis Theodossiadis; Irini Chatziralli
Journal:  J Diabetes Res       Date:  2021-08-13       Impact factor: 4.011

5.  Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.

Authors:  Sunny S Singh; Mardin Rashid; Aloysius G Lieverse; Florian Kronenberg; Claudia Lamina; Monique T Mulder; Yolanda B de Rijke; Eric J G Sijbrands; Mandy van Hoek
Journal:  Diabetologia       Date:  2020-03-09       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.